Pretzel Therapeutics is a biotech company developing first-in-class small molecule treatments that restore mitochondrial function by activating enzymes critical to mitochondrial DNA maintenance
Pretzel Therapeutics is a biotech company developing first-in-class small molecule treatments that restore mitochondrial function by activating enzymes critical to mitochondrial DNA maintenance. It employs a proprietary energetics-focused platform to modulate bioenergetic pathways across a wide spectrum of neurological, metabolic, muscle-wasting, and rare diseases, aiming to improve cellular survival and function by correcting energy regulation.